Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CINACALCET | 30MG | TABLET | Resolved | 2024-05-31 | 2024-08-02 | 229407 |
| APO-CINACALCET | 60MG | TABLET | Resolved | 2024-06-13 | 2024-09-20 | 230460 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2024-11-29 | 2024-12-20 | 244203 |
| APO-CINACALCET | 60MG | TABLET | Resolved | 2024-02-02 | 2024-03-22 | 218382 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2024-02-23 | 2024-03-22 | 220447 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2023-01-13 | 2023-01-26 | 181113 |
| APO-CINACALCET | 60MG | TABLET | Resolved | 2023-06-02 | 2023-06-16 | 193606 |
| APO-CIPROFLOX | 250MG | TABLET | Resolved | 2018-01-31 | 2018-09-09 | 37729 |
| APO-CIPROFLOX | 500MG | TABLET | Resolved | 2018-02-06 | 2018-09-09 | 38806 |
| APO-CIPROFLOX | 500MG | TABLET | Resolved | 2017-03-10 | 2017-06-12 | 107 |
| APO-CIPROFLOX | 0.3% | SOLUTION | Resolved | 2017-03-10 | 2019-06-12 | 110 |
| APO-CIPROFLOX | 500MG | TABLET | Resolved | 2017-03-20 | 2017-06-12 | 3619 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2017-03-10 | 2017-04-07 | 113 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2023-03-23 | 2023-05-06 | 187721 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2021-07-05 | 2021-07-26 | 141843 |
| APO-CITALOPRAM | 20MG | TABLET | Resolved | 2017-06-08 | 2017-11-20 | 12281 |
| APO-CITALOPRAM | 20MG | TABLET | Resolved | 2017-06-08 | 2017-10-12 | 12283 |
| APO-CITALOPRAM | 20MG | TABLET | Resolved | 2018-05-15 | 2018-10-19 | 49487 |
| APO-CITALOPRAM | 20MG | TABLET | Resolved | 2020-12-11 | 2021-03-15 | 130037 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2020-12-18 | 2021-03-15 | 130401 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
| APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |
| APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
| APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |